Pages that link to "Q35868577"

The following pages link to Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. (Q35868577):

Displaying 45 items.

• Viral vectors for gene transfer: a review of their use in the treatment of human diseases (Q28138453) (← links)
• Utilizing ras signaling pathway to direct selective replication of herpes simplex virus-1. (Q33490144) (← links)
• Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity (Q33639601) (← links)
• The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells (Q33643356) (← links)
• ICP0 inhibits the decrease of HSV amplicon-mediated transgene expression (Q33713413) (← links)
• Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins (Q33783411) (← links)
• Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells. (Q33786002) (← links)
• Long-term transgene expression in mice infected with a herpes simplex virus type 1 mutant severely impaired for immediate-early gene expression (Q33796629) (← links)
• Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry (Q33799437) (← links)
• Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. (Q33819612) (← links)
• Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival. (Q33838501) (← links)
• HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications (Q33995752) (← links)
• The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice (Q34150713) (← links)
• ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells (Q34545788) (← links)
• Characterization of a potent refractory state and persistence of herpes simplex virus 1 in cell culture (Q35024336) (← links)
• Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity. (Q35280041) (← links)
• The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27 (Q35886888) (← links)
• HSV ICP0 recruits USP7 to modulate TLR-mediated innate response (Q36105979) (← links)
• Regulatable gene expression systems for gene therapy applications: progress and future challenges (Q36157542) (← links)
• Use of Adeno-Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice (Q36370376) (← links)
• Regulatable gene expression systems for gene therapy (Q36569912) (← links)
• Herpes simplex virus ICP27 regulates alternative pre-mRNA polyadenylation and splicing in a sequence-dependent manner (Q37379851) (← links)
• Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors (Q37784704) (← links)
• Viral vectors for gene delivery to the central nervous system (Q37946113) (← links)
• Recent gene therapy advancements for neurological diseases. (Q38085469) (← links)
• Equine herpesvirus 1 gene 12 can substitute for vmw65 in the growth of herpes simplex virus (HSV) type 1, allowing the generation of optimized cell lines for the propagation of HSV vectors with multiple immediate-early gene defects (Q39550929) (← links)
• Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptor. (Q39580061) (← links)
• An enhanced packaging system for helper-dependent herpes simplex virus vectors (Q39580097) (← links)
• Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system (Q39591444) (← links)
• Herpes simplex virus type 1 immediate-early protein Vmw110 inhibits progression of cells through mitosis and from G(1) into S phase of the cell cycle. (Q39596863) (← links)
• Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection (Q39748053) (← links)
• Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification (Q39756417) (← links)
• Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis (Q39881533) (← links)
• A Herpesviral Immediate Early Protein Promotes Transcription Elongation of Viral Transcripts. (Q40161346) (← links)
• Synergistic effects of deleting multiple nonessential elements in nonreplicative HSV-1 BAC genomic vectors play a critical role in their viability. (Q40182069) (← links)
• Suppression of herpes simplex virus 1 in MDBK cells via the interferon pathway (Q40530772) (← links)
• Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo (Q40814855) (← links)
• Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. (Q40967354) (← links)
• Bovine herpesvirus 1 regulatory proteins are detected in trigeminal ganglionic neurons during the early stages of stress-induced escape from latency (Q41346393) (← links)
• Cell culture processes for the production of viral vectors for gene therapy purposes (Q41856876) (← links)
• Persistence of cyprinid herpesvirus 3 in infected cultured carp cells (Q42114353) (← links)
• And Then There Was Light: Perspectives of Optogenetics for Deep Brain Stimulation and Neuromodulation (Q47300209) (← links)
• Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System (Q58779571) (← links)
• Gene Therapy Tools for Brain Diseases (Q91938470) (← links)
• Protocol Optimization for the Production of the Non-Cytotoxic JΔNI5 HSV Vector Deficient in Expression of Immediately Early Genes (Q92002965) (← links)